Catalog Products » Glypican 1/GPC1, His, Human
Manual
Manual
COAs

Glypican 1/GPC1, His, Human

CAR-T cells targeting glypican-1 (GPC1)-specific human and murine CAR-T cells generated from our original anti-human/mouse GPC1 antibody showed strong antitumor effects in xenogeneic and syngeneic mouse models, respectively. Importantly, the murine CAR-T cells enhanced endogenous T cell responses against a non-GPC1 tumor antigen through the mechanism of antigen-spreading and showed synergistic antitumor effects with anti-PD-1 antibody without any adverse effects in syngeneic models.
$390.00
Z05360-100

Ask us a question
Product Introduction
Species Human
Protein Construction
Glypican 1/GPC1 (Asp24-Ser530)
Accession # P35052-1		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 57.1 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 70-135 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.
Back

Glypican 1/GPC1, His, Human

Immobilized Human FGF basic, No Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Glypican 1/GPC1, His, Human, His Tag with the EC50 of 11.1ng/ml determined by ELISA. »

Glypican 1/GPC1, His, Human

Immobilized Glypican 1/GPC1, His, Human, His Tag at 0.5 μg/ml(100 μl/well) on the plate. Dose response curve for Anti-Glypican 1 Antibody, hFc Tag with the EC50 of 10.3ng/ml determined by ELISA. »

Glypican 1/GPC1, His, Human

Glypican 1/GPC1, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »

<
>

Background
Target Background CAR-T cells targeting glypican-1 (GPC1)-specific human and murine CAR-T cells generated from our original anti-human/mouse GPC1 antibody showed strong antitumor effects in xenogeneic and syngeneic mouse models, respectively. Importantly, the murine CAR-T cells enhanced endogenous T cell responses against a non-GPC1 tumor antigen through the mechanism of antigen-spreading and showed synergistic antitumor effects with anti-PD-1 antibody without any adverse effects in syngeneic models.
Synonyms Glypican-1; FLJ38078; GPC1
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.